Impact of serum caffeine monitoring on adverse effects and chemotherapeutic responses to caffeine-potentiated chemotherapy for osteosarcoma

Journal of Orthopaedic Science

Volumn 14, Issue 3, 2009, Pages 253-258

  Hayashi, Katsuhiro ^a   Tsuchiya, Hiroyuki ^a   Yamamoto, Norio ^a   Shirai, Toshiharu ^a   Yamauchi, Kensuke ^a   Takeuchi, Akihiko ^a   Kawahara, Masami ^b   Miyamoto, Ken Ichi ^b   Tomita, Katsuro ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CAFFEINE; CISPLATIN; DOXORUBICIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERAMYLASEMIA; HYPONATREMIA; INSOMNIA; MALE; MENTAL IRRITATION; OSTEOSARCOMA; PRESCHOOL CHILD; SCHOOL CHILD; SEIZURE; SIDE EFFECT; UNCONSCIOUSNESS;

EID: 67649124847     PISSN: 09492658     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00776-009-1336-9     Document Type: Article

References (21)

1. G. Bacci S. Ferrari S. Lari M. Mercuri D. Donati A. Longhi 2002 Osteosarcoma of the limb: amputation or limb salvage in patients treated by neoadjuvant chemotherapy J Bone Joint Surg Br 84 88 92
2. D.L. Muscolo M.A. Ayerza L.A. Aponte-Tinao M. Ranalletta 2002 Partial epiphyseal preservation and intercalary allograft reconstruction in high-grade metaphyseal osteosarcoma of the knee J Bone Joint Surg Am 86 2686 2693 (Pubitemid 39628371)
3. M.A. Simon M.A. Aschliman N. Thomas H.J. Mankin 1986 Limb salvage treatment versus amputation for osteosarcoma of the distal end of the femur J Bone Joint Surg Am 68 1331 1337 (Pubitemid 17232206)
4. V.O. Lewis 2007 What's new in musculoskeletal oncology J Bone Joint Surg Am 89 1399 1407 (Pubitemid 46898013)
5. F. Arpaci S. Ataergin A. Ozet K. Erler M. Basbozkurt A. Ozcan 2005 The feasibility of neoadjuvant high-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with nonmetastatic high grade localized osteosarcoma: results of a phase II study Cancer 104 1058 1065 (Pubitemid 41170235)
6. H. Tsuchiya M.E. Abdel-Wanis K. Sakurakichi T. Yamashiro K. Tomita 2002 Osteosarcoma around the knee: intraepiphyseal excision and biological reconstruction with distraction osteogenesis J Bone Joint Surg Br 84 1162 1166
7. H. Tsuchiya K. Tomita Y. Mori N. Asada N. Yamamoto 1999 Marginal excision for osteosarcoma with caffeine assisted chemotherapy Clin Orthop 358 27 35 (Pubitemid 29066071)
8. H. Tsuchiya K. Tomita H. Yasutake Y. Takagi S. Katsuo Y. Tokuumi 1994 Intraarterial cisplatin and caffeine with/without doxorubicin for musculoskeletal high-grade spindle cell sarcoma Oncol Rep 1 27 36 (Pubitemid 2015051)
9. Y. Kanazawa H. Tsuchiya A. Nonomura K. Takazawa N. Yamamoto K. Tomita 2003 Intentional marginal excision of osteosarcoma of the proximal fibula to preserve limb function J Orthop Sci 8 757 761 (Pubitemid 38017660)
10. M. Hayashi H. Tsuchiya N. Yamamoto M. Karita T. Shirai H. Nishida 2005 Caffeine-potentiated chemotherapy for metastatic carcinoma and lymphoma of bone and soft tissue Anticancer Res 25 2399 2406
11. A. Takeuchi H. Tsuchiya N. Yamamoto K. Hayashi K. Yamauchi M. Kawahara 2007 Caffeine-potentiated chemotherapy for patients with high-grade soft tissue sarcoma: long-term clinical outcome Anticancer Res 27 3489 3496
12. K. Hayashi H. Tsuchiya N. Yamamoto A. Takeuchi K. Tomita 2008 Functional outcome in patients with osteosarcoma around the knee joint treated by minimised surgery Int Orthop 32 63 68 (Pubitemid 351170102)
13. M. Kawahara H. Kagiyama Y. Kanazawa H. Tsuchiya K. Tomita K. Yokogawa 2004 Rapid determination method of caffeine and application to monitoring of caffeine-assisted chemotherapy Biopharm Drug Dispos 25 61 67 (Pubitemid 38425535)
14. R.R. Dalvi 1986 Acute and chronic toxicity of caffeine: a review Vet Hum Toxicol 28 144 150 (Pubitemid 16138778)
15. Gibaldi M, Perrier D. One-compartment model. In: Pharmacokinetics. 2nd edn. New York: Marcel Dekker; 1982. p. 27-32.
16. K. Tobinai A. Kohno Y. Shimada T. Watanabe T. Tamura K. Takeyama 1993 Toxicity grading criteria of the Japan Clinical Oncology Group; The Clinical Trial Review Committee of the Japan Clinical Oncology Group Jpn J Clin Oncol 23 250 257
17. J.E. Byfield J. Murnane J.F. Ward P. Calabro-Jones M. Lynch F. Kulhanian 1981 Mice, men, mustards and methylated xanthines: the potential role of caffeine and related drugs in the sensitization of human tumours to alkylating agents Br J Cancer 43 669 683
18. H.W. Van Den Berg J.J. Roberts 1976 Inhibition by caffeine of post-replication repair in Chinese hamster cells treated with cis platinum (II) diamminedichloride: the extent of platinum binding to template DNA in relation to the size of low molecular weight nascent DNA Chem Biol Interact 12 375 390
19. K. Tomita H. Tsuchiya 1989 Enhancement of cytocidal and antitumor effect of cisplatin by caffeine in human osteosarcoma Clin Ther 11 43 52 (Pubitemid 19112875)
20. K. Tomita H. Tsuchiya 1989 Caffeine enhancement of the effect of anticancer agents on human sarcoma cells Jpn J Cancer Res 80 83 88 (Pubitemid 20027203)
21. H. Yasutake H. Tsuchiya K. Tomita T. Matsunaga O. Nikaido T. Mori 1995 Inhibitory effect of caffeine on potentially lethal damage repair in cisplatin-treated human osteosarcoma cells Anticancer Res 15 831 838